• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Petco Health + Wellness Company, Inc. Reports First Quarter 2025 Financial Results

    6/5/25 4:05:00 PM ET
    $WOOF
    Other Specialty Stores
    Consumer Discretionary
    Get the next $WOOF alert in real time by email

    Reaffirms Fiscal 2025 Net Sales and Earnings Outlook*

    SAN DIEGO, June 5, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced its first quarter 2025 financial results.

    Petco Health + Wellness Company, Inc. Logo (PRNewsfoto/Petco Health and Wellness Company, Inc.)

    Q1 2025 Overview

    • Net sales of $1.5 billion decreased 2.3% year over year in line with the company's first quarter outlook
    • Comparable sales decreased 1.3% year over year
    • Gross profit margin expanded approximately 30 basis points to 38.2% as a percentage of net sales
    • Operating Income improved $33.1 million to $16.4 million
    • GAAP net loss improved $34.8 million to $11.7 million
    • Adjusted EBITDA1 increased $13.8 million to $89.4 million

    "We are pleased to deliver first quarter earnings results ahead of our guidance and to reaffirm our outlook for fiscal 2025 which now incorporates the impact of tariffs. This performance is a testament to the execution of our nearly 30,000 team members and the resilience of the category in which we operate," said Joel Anderson, Petco's Chief Executive Officer.

    "We entered the year with a detailed, phased strategy to strengthen retail fundamentals across our operating model and return the business to sustainable, profitable growth. The current backdrop has served as a catalyst to accelerate the work that was already underway. We are pleased with the progress we are continuing to drive, and our entire team remains focused on executing our plans and driving the performance we know this business is capable of."

    Full Year 2025 Outlook

    The company reaffirmed its full year 2025 net sales and earnings outlook and provided its outlook for the second quarter of 2025. The Company's second quarter and full year 2025 guidance assumes that the current tariffs on imports into the U.S. from China and other countries as of June 5, 2025 will stay at current levels and do not increase for the remainder of the year.



    FY 2025 Outlook*

        Net Sales

    Down low single digits year over year

        Adjusted EBITDA

    $375 million to $390 million

        Net interest expense

    ~$130 million

        Capital Expenditures

    $125 million to $130 million

        Depreciation & Amortization

    ~$200 million

     

    Second Quarter 2025 Outlook



    Q2 2025 Outlook*

        Net Sales

    Down low single digits year over year

    Adjusted EBITDA

    $92 million to $94 million

     

    *Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent, and that current tariffs on imports into the U.S. from other countries remain at June 5, 2025 levels. Adjusted EBITDA is a non-GAAP financial measure and has not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

    (1)

    Adjusted EBITDA and Free Cash Flow are non-GAAP financial measures. See "Non-GAAP Financial Measures" for additional information on non-GAAP financial measures and a reconciliation to the most comparable GAAP measures.

    Earnings Conference Call Webcast Information:

    Management will host an earnings conference call on June 5, 2025 at approximately 4:30 PM Eastern Time to discuss the company's financial results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after the conference call. 

    About Petco, The Health + Wellness Co.:

    Founded in 1965, Petco is a category-defining health and wellness company focused on improving the lives of pets, pet parents and our own Petco partners. We've consistently set new standards in pet care while delivering comprehensive pet wellness products, services and solutions, and creating communities that deepen the pet-pet parent bond. We operate more than 1,500 pet care centers across the U.S., Mexico and Puerto Rico, which offer merchandise, companion animals, grooming, training and a growing network of on-site veterinary hospitals and mobile veterinary clinics. Our complete pet health and wellness ecosystem is accessible through our pet care centers and digitally at petco.com and on the Petco app. In tandem with Petco Love, a life-changing independent nonprofit organization, we work with and support thousands of local animal welfare groups across the country and, through in-store adoption events, we've helped find homes for approximately 7 million animals.

    Forward-Looking Statements:

    This earnings release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 as contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, concerning expectations, beliefs, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements that are not statements of historical fact, including, but not limited to, statements regarding our Q2 and full year 2025 guidance, operational reset of our business, our competitive positioning, profitability, cost action plans and associated cost-savings, and our expectations regarding tariffs and associated impacts. Such forward-looking statements can generally be identified by the use of forward-looking terms such as "believes," "expects," "may," "intends," "will," "shall," "should," "anticipates," "opportunity," "illustrative," or the negative thereof or other variations thereon or comparable terminology. Although Petco believes that the expectations and assumptions reflected in these statements are reasonable, there can be no assurance that these expectations will prove to be correct or that any forward-looking results will occur or be realized. Nothing contained in this earnings release is, or should be relied upon as, a promise or representation or warranty as to any future matter, including any matter in respect of the operations or business or financial condition of Petco. All forward-looking statements are based on current expectations and assumptions about future events that may or may not be correct or necessarily take place and that are by their nature subject to significant uncertainties and contingencies, many of which are outside the control of Petco. Forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results or events to differ materially from the potential results or events discussed in the forward-looking statements, including, without limitation, those identified in this earnings release as well as the following: (i) increased competition (including from multi-channel retailers, mass and grocery retailers, and e-Commerce providers); (ii) reduced consumer demand for our products and/or services; (iii) our reliance on key vendors; (iv) our ability to attract and retain qualified employees; (v) risks arising from statutory, regulatory and/or legal developments; (vi) macroeconomic pressures in the markets in which we operate, including inflation, prevailing interest rates and the impact of tariffs; (vii) failure to effectively manage our costs; (viii) our reliance on our information technology systems; (ix) our ability to prevent or effectively respond to a data privacy or security breach; (x) our ability to effectively manage or integrate strategic ventures, alliances or acquisitions and realize the anticipated benefits of such transactions; (xi) economic or regulatory developments that might affect our ability to provide attractive promotional financing; (xii) business interruptions and other supply chain issues; (xiii) catastrophic events, political tensions, conflicts and wars (such as the ongoing conflicts in Ukraine and the Middle East), health crises, and pandemics; (xiv) our ability to maintain positive brand perception and recognition; (xv) product safety and quality concerns; (xvi) changes to labor or employment laws or regulations; (xvii) our ability to effectively manage our real estate portfolio; (xviii) constraints in the capital markets or our vendor credit terms; (xix) changes in our credit ratings; (xx) impairments of the carrying value of our goodwill and other intangible assets; (xxi) our ability to successfully implement our operational adjustments, achieve the expected benefits of our cost action plans and drive improved profitability; and (xxii) the other risks, uncertainties and other factors identified under "Risk Factors"  and elsewhere in Petco's Securities and Exchange Commission filings. The occurrence of any such factors could significantly alter the results set forth in these statements.

    Petco cautions that the foregoing list of risks, uncertainties and other factors is not complete, and forward-looking statements speak only as of the date they are made. Petco undertakes no duty to update publicly any such forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by applicable law, regulation or other competent legal authority.

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)





















    13 Weeks Ended







    May 3,

    2025



    May 4,

    2024



    Percent

    Change



    Net sales:















    Products



    $   1,241,891



    $   1,279,731



    (3 %)



    Services and other



    251,508



    249,409



    1 %



    Total net sales



    1,493,399



    1,529,140



    (2 %)



    Cost of sales:















    Products



    766,285



    792,722



    (3 %)



    Services and other



    157,146



    157,758



    (0 %)



    Total cost of sales



    923,431



    950,480



    (3 %)



    Gross profit



    569,968



    578,660



    (2 %)



    Selling, general and administrative expenses



    553,609



    595,442



    (7 %)



    Operating income (loss)



    16,359



    (16,782)



    N/M



    Interest income



    (1,359)



    (418)



    225 %



    Interest expense



    33,494



    36,817



    (9 %)



    Other non-operating loss



    —



    2,665



    (100 %)



    Loss before income taxes and income from

       equity method investees



    (15,776)



    (55,846)



    (72 %)



    Income tax expense (benefit)



    495



    (4,477)



    N/M



    Income from equity method investees



    (4,610)



    (4,886)



    (6 %)



    Net loss attributable to Class A and B-1 common

       stockholders



    $      (11,661)



    $      (46,483)



    (75 %)



















    Net loss per Class A and B-1 common share:















    Basic



    $           (0.04)



    $           (0.17)



    (76 %)



    Diluted



    $           (0.04)



    $           (0.17)



    (76 %)



















    Weighted average shares used in computing net loss per Class A

       and B-1 common share:















    Basic



    277,548



    269,768



    3 %



    Diluted



    277,548



    269,768



    3 %



     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED BALANCE SHEETS

    (In thousands, except per share amounts)

    (Unaudited and subject to reclassification)











     May 3,

    2025 



     February 1,

    2025 

    ASSETS









    Current assets:









    Cash and cash equivalents



    $      133,343



    $      165,756

    Receivables, less allowance for credit losses1



    36,079



    40,425

    Merchandise inventories, net



    645,472



    653,329

    Prepaid expenses



    66,973



    53,515

    Other current assets



    38,563



    60,594

    Total current assets



    920,430



    973,619

    Fixed assets



    2,284,663



    2,265,915

    Less accumulated depreciation



    (1,580,210)



    (1,540,477)

    Fixed assets, net



    704,453



    725,438

    Operating lease right-of-use assets



    1,300,032



    1,302,346

    Goodwill



    980,064



    980,064

    Trade name



    1,025,000



    1,025,000

    Other long-term assets



    191,157



    187,963

    Total assets



    $   5,121,136



    $   5,194,430

    LIABILITIES AND EQUITY









    Current liabilities:









    Accounts payable and book overdrafts



    $      473,906



    $      492,878

    Accrued salaries and employee benefits



    108,909



    157,460

    Accrued expenses and other liabilities



    190,239



    177,079

    Current portion of operating lease liabilities



    305,051



    306,400

    Current portion of long-term debt and other lease liabilities



    5,372



    5,346

    Total current liabilities



    1,083,477



    1,139,163

    Senior secured credit facilities, net, excluding current portion



    1,579,338



    1,578,091

    Operating lease liabilities, excluding current portion



    1,034,719



    1,037,206

    Deferred taxes, net



    207,709



    217,712

    Other long-term liabilities



    108,563



    108,628

    Total liabilities



    4,013,806



    4,080,800

    Commitments and contingencies









    Stockholders' equity:









    Class A common stock2



    241



    239

    Class B-1 common stock3



    38



    38

    Class B-2 common stock4



    —



    —

    Preferred stock5



    —



    —

    Additional paid-in-capital



    2,288,248



    2,280,495

    Accumulated deficit



    (1,160,720)



    (1,149,059)

    Accumulated other comprehensive loss



    (20,477)



    (18,083)

    Total stockholders' equity



    1,107,330



    1,113,630

    Total liabilities and stockholders' equity



    $   5,121,136



    $   5,194,430

     

    (1)

    Allowances for credit losses are $859 and $1,594, respectively

    (2)

    Class A common stock, $0.001 par value: Authorized - 1.0 billion shares; Issued and outstanding - 240.8 million and 239.1 million shares, respectively

    (3)

    Class B-1 common stock, $0.001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (4)

    Class B-2 common stock, $0.000001 par value: Authorized - 75.0 million shares; Issued and outstanding - 37.8 million shares

    (5)

    Preferred stock, $0.001 par value: Authorized - 25.0 million shares; Issued and outstanding – none

     

    PETCO HEALTH AND WELLNESS COMPANY, INC.

    CONSOLIDATED STATEMENTS OF CASH FLOWS

    (In thousands)

    (Unaudited and subject to reclassification)















    13 Weeks Ended





    May 3,

    2025



    May 4,

    2024

    Cash flows from operating activities:









    Net loss



    $      (11,661)



    $      (46,483)

    Adjustments to reconcile net loss to net cash used in

      operating activities:









    Depreciation and amortization



    49,365



    49,587

    Amortization of debt discounts and issuance costs



    1,246



    1,218

    Provision for deferred taxes



    (9,218)



    (13,365)

    Equity-based compensation



    9,420



    17,434

    Impairments, write-offs and losses on sale of fixed and other assets



    446



    3,508

    Income from equity method investees



    (4,610)



    (4,886)

    Amounts reclassified out of accumulated other comprehensive loss



    (212)



    (1,129)

    Non-cash operating lease costs



    102,132



    103,637

    Other non-operating loss



    —



    2,665

    Changes in assets and liabilities:









        Receivables



    4,229



    2,987

        Merchandise inventories



    7,857



    3,076

        Prepaid expenses and other assets



    (1,673)



    (4,511)

        Accounts payable and book overdrafts



    (19,028)



    (19,538)

        Accrued salaries and employee benefits



    (51,130)



    (5,474)

        Accrued expenses and other liabilities



    12,426



    5,902

        Operating lease liabilities



    (103,780)



    (104,181)

        Other long-term liabilities



    (1,263)



    1,139

          Net cash used in operating activities



    (15,454)



    (8,414)

    Cash flows from investing activities:









    Cash paid for fixed assets



    (28,412)



    (32,641)

    Cash paid for acquisitions, net of cash acquired



    —



    (100)

    Proceeds from investments



    —



    998

    Proceeds from sale of assets



    1,279



    —

          Net cash used in investing activities



    (27,133)



    (31,743)

    Cash flows from financing activities:









    Borrowings under long-term debt agreements



    —



    173,000

    Repayments of long-term debt



    —



    (173,000)

    Debt refinancing costs



    —



    (2,955)

    Payments for finance lease liabilities



    (1,143)



    (1,444)

    Proceeds from employee stock purchase plan and stock option exercises



    967



    830

    Tax withholdings on stock-based awards



    (158)



    (2,059)

          Net cash used in financing activities



    (334)



    (5,628)











    Net decrease in cash, cash equivalents and restricted cash



    (42,921)



    (45,785)

    Cash, cash equivalents and restricted cash at beginning of period



    181,665



    136,649

    Cash, cash equivalents and restricted cash at end of period



    $      138,744



    $        90,864

     

    NON-GAAP FINANCIAL MEASURES

    The following information provides definitions and reconciliations of the non-GAAP financial measures presented in this earnings release to the most directly comparable financial measures calculated and presented in accordance with generally accepted accounting principles (GAAP). The company has provided this non-GAAP financial information, which is not calculated or presented in accordance with GAAP, as information supplemental and in addition to the financial measures presented in this earnings release that are calculated and presented in accordance with GAAP. Such non-GAAP financial measures should not be considered superior to, as a substitute for or alternative to, and should be considered in conjunction with, the GAAP financial measures presented in this earnings release. The non-GAAP financial measures in this earnings release may differ from similarly titled measures used by other companies.

    The tables below reflect the calculation of Adjusted EBITDA as applicable, for the thirteen weeks ended May 3, 2025 compared to the thirteen weeks ended May 4, 2024.

    Adjusted EBITDA

    Adjusted EBITDA is considered a non-GAAP financial measure under the Securities and Exchange Commission's (SEC) rules because it excludes certain amounts included in net income calculated in accordance with GAAP. Management believes that Adjusted EBITDA is a meaningful measure to share with investors because it facilitates comparison of the current period performance with that of the comparable prior period. In addition, Adjusted EBITDA affords investors a view of what management considers to be Petco's core operating performance as well as the ability to make a more informed assessment of such operating performance as compared with that of the prior period. Please see the company's Annual Report on Form 10-K for the fiscal year ended February 1, 2025 filed with the SEC on March 31, 2025 for additional information on Adjusted EBITDA.

    (dollars in thousands)



    13 Weeks Ended

    Reconciliation of Net Loss Attributable to Class A and B-1

       Common Stockholders to Adjusted EBITDA



    May 3,

    2025



    May 4,

    2024

    Net loss attributable to Class A and B-1 common stockholders



    $      (11,661)



    $      (46,483)

    Add (deduct):









    Interest expense, net



    32,135



    36,399

    Income tax expense (benefit)



    495



    (4,477)

    Depreciation and amortization



    49,365



    49,587

    Income from equity method investees



    (4,610)



    (4,886)

    Asset impairments and write offs



    446



    3,508

    Equity-based compensation



    9,420



    17,434

    Other non-operating loss



    —



    2,665

    Mexico joint venture EBITDA (1)



    10,198



    10,496

    Acquisition and divestiture-related costs (2)



    —



    3,719

    Other costs (3)



    3,661



    7,682

    Adjusted EBITDA



    $        89,449



    $        75,644

    Net sales



    $   1,493,399



    $   1,529,140

    Net margin (4)



    (0.8 %)



    (3.0 %)

    Adjusted EBITDA Margin



    6.0 %



    4.9 %

     

    Free Cash Flow

    Free Cash Flow is a non-GAAP financial measure that is calculated as net cash provided by operating activities less cash paid for fixed assets. Management believes that Free Cash Flow, which measures the ability to generate additional cash from business operations, is an important financial measure for use in evaluating the company's financial performance.

    The table below reflects the calculation of Free Cash Flow for the thirteen weeks ended May 3, 2025 compared to the thirteen weeks ended May 4, 2024.

    (in thousands)



    13 Weeks Ended





    May 3,

    2025



    May 4,

    2024

    Net cash used in operating activities



    $      (15,454)



    $        (8,414)

    Cash paid for fixed assets



    (28,412)



    (32,641)

    Free Cash Flow



    $      (43,866)



    $      (41,055)

     

    Non-GAAP Financial Measures Footnotes

    (1)

    Mexico Joint Venture EBITDA represents 50 percent of the entity's operating results for all periods, as adjusted to reflect the results on a basis comparable to Adjusted EBITDA. In the financial statements, this joint venture is accounted for as an equity method investment and reported net of depreciation and income taxes because such a presentation would not reflect the adjustments made in the calculation of Adjusted EBITDA, we include the 50 percent interest in the company's Mexico joint venture on an Adjusted EBITDA basis to ensure consistency. The table below presents a reconciliation of Mexico joint venture net income to Mexico joint venture EBITDA.

     





    13 Weeks Ended

    (in thousands)



    May 3,

    2025



    May 4,

    2024

    Net income



    $          9,220



    $          9,555

    Depreciation



    6,597



    6,948

    Income tax expense



    4,166



    3,456

    Foreign currency (gain) loss



    (292)



    479

    Interest expense, net



    704



    553

    EBITDA



    $        20,395



    $        20,991

    50% of EBITDA



    $        10,198



    $        10,496

     

    (2)

    Acquisition and divestiture-related integration costs include direct costs resulting from acquiring, integrating, or divesting businesses. These include third-party professional and legal fees, losses on sales of divestitures, and other integration-related costs that would not have otherwise been incurred as part of the company's operations.





    (3)

    Other costs include, as incurred: restructuring costs and restructuring-related severance costs; legal reserves associated with significant, non-ordinary course legal or regulatory matters; and costs related to certain significant strategic transactions.





    (4)

    We define net margin as net loss attributable to Class A and B-1 common stockholders divided by net sales and Adjusted EBITDA margin as Adjusted EBITDA divided by net sales.

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/petco-health--wellness-company-inc-reports-first-quarter-2025-financial-results-302474589.html

    SOURCE Petco - Investor Relations

    Get the next $WOOF alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WOOF

    DatePrice TargetRatingAnalyst
    7/19/2024$3.00 → $4.00Neutral
    Citigroup
    4/2/2024$5.00 → $1.50Buy → Underperform
    BofA Securities
    12/19/2023$3.11Hold
    Jefferies
    11/30/2023$8.00 → $3.00Outperform → Neutral
    Robert W. Baird
    11/29/2023Overweight → Equal Weight
    Wells Fargo
    9/29/2023Peer Perform
    Wolfe Research
    8/25/2023$10.00 → $7.00Outperform
    RBC Capital Mkts
    4/28/2023$10.00Hold
    Gordon Haskett
    More analyst ratings

    $WOOF
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Citigroup reiterated coverage on Petco Health and Wellness with a new price target

      Citigroup reiterated coverage of Petco Health and Wellness with a rating of Neutral and set a new price target of $4.00 from $3.00 previously

      7/19/24 8:30:14 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness downgraded by BofA Securities with a new price target

      BofA Securities downgraded Petco Health and Wellness from Buy to Underperform and set a new price target of $1.50 from $5.00 previously

      4/2/24 7:46:18 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Jefferies initiated coverage on Petco Health and Wellness with a new price target

      Jefferies initiated coverage of Petco Health and Wellness with a rating of Hold and set a new price target of $3.11

      12/19/23 6:54:34 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Financials

    Live finance-specific insights

    See more
    • Petco Health + Wellness Company, Inc. Reports First Quarter 2025 Financial Results

      Reaffirms Fiscal 2025 Net Sales and Earnings Outlook* SAN DIEGO, June 5, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced its first quarter 2025 financial results. Q1 2025 Overview Net sales of $1.5 billion decreased 2.3% year over year in line with the company's first quarter outlookComparable sales decreased 1.3% year over yearGross profit margin expanded approximately 30 basis points to 38.2% as a percentage of net salesOperating Income improved $33.1 million to $16.4 millionGAAP net loss improved $34.8 million to $11.7 millionAdjus

      6/5/25 4:05:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness Company, Inc. to Host First Quarter 2025 Earnings Conference Call on June 5, 2025

      SAN DIEGO, May 15, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced that its financial results for the first quarter fiscal 2025 will be released after market close on Thursday, June 5, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after t

      5/15/25 4:05:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health + Wellness Company, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

      Expects Double-Digit Adjusted EBITDA Growth in 2025* SAN DIEGO, March 26, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced its fourth quarter and full year 2024 financial results. Q4 2024 Overview Net revenue of $1.6 billion decreased 7.3% year over year inclusive of the negative impact from the loss of the 53rd week in 2023Comparable sales increased 0.5% year over yearGross profit of $589.3 million decreased 2.8% year over year compared to $606.3 million last yearGAAP net loss of $13.8 million compared to GAAP net loss of $22.6 millio

      3/26/25 4:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Leadership Updates

    Live Leadership Updates

    See more
    • PETCO STRENGTHENS LEADERSHIP TEAM WITH APPOINTMENT OF THREE PROVEN EXECUTIVES

      Sabrina Simmons Appointed Chief Financial Officer Michael Romanko Appointed Chief Customer and Product Officer Jack Stout Appointed Chief Merchandising Officer SAN DIEGO, Feb. 18, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced the appointment of three new leaders to Petco's executive team to support accelerated operational improvement and position the business for a faster return to profitable growth. Sabrina Simmons, former Chief Financial Officer at Gap, Inc., has been named Chief Financial Officer, effective February 17.Michael

      2/18/25 4:10:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Names Joe Venezia Chief Revenue Officer

      SAN DIEGO, Nov. 13, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced Joe Venezia will join the company as Chief Revenue Officer, effective Nov. 17, reporting to Joel Anderson, Chief Executive Officer. In this newly created role, Venezia will be responsible for driving revenue and developing integrated strategies to improve the customer experience. Joe will oversee critical areas that contribute to Petco's growth, including pet care centers, pet and veterinary services, real estate and customer success capabilities. "Joe is a proven sal

      11/13/24 8:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Names Joel D. Anderson as Chief Executive Officer

      30-Year Retail Industry Veteran Named Chief Executive Officer and Member of the Board of Directors R. Michael Mohan to Lead a New Board Committee Focused on Value Creation SAN DIEGO, July 17, 2024 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced that the Company's Board of Directors has appointed Joel D. Anderson to serve as Chief Executive Officer (CEO), effective July 29, 2024. In addition, Anderson has been elected to serve on the Company's Board of Directors. "Joel is an inspirational leader and a highly experienced retail CEO," said Gl

      7/17/24 4:02:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Anderson Joel D was granted 5,000 shares, increasing direct ownership by 0.16% to 3,225,181 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      5/6/25 6:17:14 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Officer Insana Giovanni covered exercise/tax liability with 49,948 shares, decreasing direct ownership by 10% to 470,147 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      4/17/25 6:28:39 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Chief Human Resources Officer May Holly covered exercise/tax liability with 146,204 shares, decreasing direct ownership by 7% to 2,021,388 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      4/17/25 6:27:08 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    SEC Filings

    See more
    • SEC Form 10-Q filed by Petco Health and Wellness Company Inc.

      10-Q - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

      6/6/25 4:05:40 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness Company Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

      6/5/25 4:10:21 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form DEFA14A filed by Petco Health and Wellness Company Inc.

      DEFA14A - Petco Health & Wellness Company, Inc. (0001826470) (Filer)

      5/30/25 4:33:19 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

      SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

      2/14/24 12:55:28 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Petco Health and Wellness Company Inc. (Amendment)

      SC 13G/A - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

      2/14/24 6:00:20 AM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • SEC Form SC 13G filed by Petco Health and Wellness Company Inc.

      SC 13G - Petco Health & Wellness Company, Inc. (0001826470) (Subject)

      2/14/22 4:43:20 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Anderson Joel D bought $4,717,461 worth of shares (1,586,088 units at $2.97) (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      4/1/25 7:14:43 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Breitner Cameron bought $2,354,325 worth of shares (750,000 units at $3.14) (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      5/29/24 7:35:36 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Briggs Gary S bought $99,924 worth of shares (30,000 units at $3.33), increasing direct ownership by 75% to 70,085 units (SEC Form 4)

      4 - Petco Health & Wellness Company, Inc. (0001826470) (Issuer)

      12/4/23 7:29:44 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary

    $WOOF
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Petco Health + Wellness Company, Inc. Reports First Quarter 2025 Financial Results

      Reaffirms Fiscal 2025 Net Sales and Earnings Outlook* SAN DIEGO, June 5, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) today announced its first quarter 2025 financial results. Q1 2025 Overview Net sales of $1.5 billion decreased 2.3% year over year in line with the company's first quarter outlookComparable sales decreased 1.3% year over yearGross profit margin expanded approximately 30 basis points to 38.2% as a percentage of net salesOperating Income improved $33.1 million to $16.4 millionGAAP net loss improved $34.8 million to $11.7 millionAdjus

      6/5/25 4:05:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco Health and Wellness Company, Inc. to Host First Quarter 2025 Earnings Conference Call on June 5, 2025

      SAN DIEGO, May 15, 2025 /PRNewswire/ -- Petco Health and Wellness Company, Inc. (NASDAQ:WOOF), today announced that its financial results for the first quarter fiscal 2025 will be released after market close on Thursday, June 5, 2025. The company will host a conference call at 4:30 p.m. Eastern time to discuss the results. A live webcast of the conference call will be available on the company's Investor Relations page at https://ir.petco.com/news-and-events/events-and-presentations. A replay of the webcast will be available through the same link approximately two hours after t

      5/15/25 4:05:00 PM ET
      $WOOF
      Other Specialty Stores
      Consumer Discretionary
    • Petco joins Uber Eats for Nationwide On-Demand Delivery

      Today Uber Technologies, Inc. (NYSE:UBER) and Petco Health and Wellness Company, Inc. (NASDAQ:WOOF) announced a new partnership that brings Petco's wide selection of pet essentials to the Uber Eats platform, making it easier than ever for pet parents to get what they need, when they need it. With all Petco locations in the contiguous United States now available on Uber Eats, customers can shop for on-demand or scheduled delivery of pet food, toys, treats, and other essentials—all at the tap of a button. Starting today, pet parents can browse and purchase Petco's curated assortment of high-quality products directly through the Uber Eats app, with convenient delivery options that fit their b

      3/27/25 9:00:00 AM ET
      $UBER
      $WOOF
      Business Services
      Consumer Discretionary
      Other Specialty Stores